Literature DB >> 30884371

Depression and aging with HIV: Associations with health-related quality of life and positive psychological factors.

Alexandra S Rooney1, Raeanne C Moore2, Emily W Paolillo3, Ben Gouaux1, Anya Umlauf1, Scott L Letendre4, Dilip V Jeste5, David J Moore6.   

Abstract

BACKGROUND: Depression is prevalent among persons living with HIV (PLWH). This study investigated the relationships between depressive symptomatology, health-related quality of life (HRQoL), and positive psychological factors in PLWH and age-matched HIV-individuals.
METHODS: One hundred twenty-two PLWH and 94 HIV- individuals, recruited in three age cohorts (36-45, 46-55, 56-65 years old), completed self-report questionnaires on depressive symptoms (CES-D), HRQoL, and positive psychological factors (resilience, grit, and self-rated successful aging [SRSA]). Participants were classified based on HIV status (H+ vs H-) and elevated depressive symptoms (D+ vs D-) into four groups (H+/D+; H-/D+; H+/D-; H-/D-).
RESULTS: Fifty-eight percent of PLWH had elevated depressive scores, compared to 33% of HIV- individuals (p < 0.001). The proportion of individuals reporting elevated depressive symptoms only differed among individuals 36-45 years old (H+: 61.5%; H-: 17.9%; p < 0.001). Individuals in the H+/D+ group reported the lowest HRQoL, resilience, grit, and SRSA across age cohorts. However, there were no differences on HRQoL or positive psychological factors between H+/D- and H-/D- groups; in fact, individuals 56-65 years in the H+/D- group endorsed aging the most successfully. LIMITATIONS: Small sample size within the groups and the cross-sectional nature of the analysis limit the ability to address onset of depressive symptoms in relation to HRQoL or positive psychological factors.
CONCLUSIONS: Among PLWH depressive symptoms show a strong association with HRQoL and positive psychological factors compared to HIV- individuals. In the absence of elevated depressive symptoms, however, PLWH report similar HRQoL and positive psychological factors to HIV- individuals.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2019        PMID: 30884371      PMCID: PMC6705595          DOI: 10.1016/j.jad.2019.03.025

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  48 in total

Review 1.  Neuropsychiatric aspects of HIV infection among older adults.

Authors:  C H Hinkin; S A Castellon; J H Atkinson; K Goodkin
Journal:  J Clin Epidemiol       Date:  2001-12       Impact factor: 6.437

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  The evaluation of depression in inpatients with HIV disease.

Authors:  A Cockram; F K Judd; A Mijch; T Norman
Journal:  Aust N Z J Psychiatry       Date:  1999-06       Impact factor: 5.744

4.  Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women.

Authors:  J A Cook; D Grey; J Burke-Miller; M H Cohen; K Anastos; M Gandhi; J Richardson; T Wilson; M Young
Journal:  AIDS Care       Date:  2006-02

5.  Mortality prediction with a single general self-rated health question. A meta-analysis.

Authors:  Karen B DeSalvo; Nicole Bloser; Kristi Reynolds; Jiang He; Paul Muntner
Journal:  J Gen Intern Med       Date:  2005-12-07       Impact factor: 5.128

6.  The effect of changes in depression on health related quality of life (HRQoL) in HIV infection.

Authors:  Andrew J Elliott; Joan Russo; Peter P Roy-Byrne
Journal:  Gen Hosp Psychiatry       Date:  2002 Jan-Feb       Impact factor: 3.238

7.  Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort.

Authors:  P Braitstein; V Montessori; K Chan; J S G Montaner; M T Schechter; M V O'Shaughnessy; R S Hogg
Journal:  AIDS Care       Date:  2005-05

Review 8.  Mood and substance use disorders in older adults with HIV/AIDS: methodological issues and preliminary evidence.

Authors:  Judith G Rabkin; Martin C McElhiney; Stephen J Ferrando
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

9.  Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment.

Authors:  M Préau; C Leport; D Salmon-Ceron; P Carrieri; H Portier; G Chene; B Spire; P Choutet; F Raffi; M Morin
Journal:  AIDS Care       Date:  2004-07

10.  Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection.

Authors:  Dwight L Evans; Thomas R Ten Have; Steven D Douglas; David R Gettes; Mary Morrison; Margaret S Chiappini; Priscilla Brinker-Spence; Carla Job; Delinda E Mercer; Yan Lin Wang; Dean Cruess; Benoit Dube; Erik A Dalen; Tiffany Brown; Russell Bauer; John M Petitto
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

View more
  20 in total

1.  Felt Age Discrepancy Differs by HIV Serostatus: A Secondary Analysis.

Authors:  Maulika Kohli; Lily Kamalyan; Elizabeth C Pasipanodya; Anya Umlauf; Raeanne C Moore; Scott L Letendre; Dilip V Jeste; David J Moore
Journal:  J Assoc Nurses AIDS Care       Date:  2020 Sep-Oct       Impact factor: 1.354

2.  Social support moderates D-dimer and self-rated successful aging within people with HIV and older adults.

Authors:  Ni Sun-Suslow; Elizabeth Pasipanodya; Erin Morgan; Maulika Kohli; Vanessa Serrano; Scott Letendre; Dilip V Jeste; David J Moore
Journal:  J Behav Med       Date:  2020-02-18

3.  Four-Year Trajectories of Internal Strengths and Socioemotional Support Among Middle-Aged and Older Adults with HIV.

Authors:  Lillian Ham; Bin Tang; Maulika Kohli; Dilip V Jeste; Igor Grant; David J Moore
Journal:  AIDS Behav       Date:  2022-07-31

4.  Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances.

Authors:  Caitlin N Pope; Jessica L Montoya; Elizabeth Vasquez; Josué Pérez-Santiago; Ronald Ellis; J Allen McCutchan; Dilip V Jeste; David J Moore; María J Marquine
Journal:  J Neurovirol       Date:  2020-07-30       Impact factor: 2.643

5.  HIV and three dimensions of Wisdom: Association with cognitive function and physical and mental well-being: For: Psychiatry Research.

Authors:  Elizabeth Vásquez; Ellen E Lee; Weihui Zhang; Xin Tu; David J Moore; María J Marquine; Dilip V Jeste
Journal:  Psychiatry Res       Date:  2020-10-15       Impact factor: 3.222

6.  Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease.

Authors:  Rowan Saloner; Mariana Cherner; David J Grelotti; Emily W Paolillo; David J Moore; Robert K Heaton; Scott L Letendre; Adarsh Kumar; Igor Grant; Ronald J Ellis
Journal:  Brain Behav Immun       Date:  2020-09-20       Impact factor: 7.217

7.  The effect of varenicline on mood and cognition in smokers with HIV.

Authors:  Morgan Thompson; Robert Schnoll; Katrina Serrano; Frank Leone; Robert Gross; Ronald G Collman; Rebecca L Ashare
Journal:  Psychopharmacology (Berl)       Date:  2020-01-14       Impact factor: 4.530

8.  Brain-derived neurotrophic factor (BDNF) is associated with depressive symptoms in older adults with HIV disease.

Authors:  Steven Paul Woods; Michelle Babicz; Lokesh Shahani; Gabriela Delevati Colpo; Erin E Morgan; Antonio L Teixeira
Journal:  J Neurovirol       Date:  2020-11-03       Impact factor: 2.643

9.  A Cross-Sectional Study to Evaluate the Effects of Age and Duration of HIV Infection on Anxiety and Depression in Cisgender Men.

Authors:  Sara Gianella; Rowan Saloner; Genevieve Curtin; Susan J Little; Anne Heaton; Jessica L Montoya; Scott L Letendre; María J Marquine; Dilip V Jeste; David J Moore
Journal:  AIDS Behav       Date:  2021-07-21

10.  Depression is associated with hippocampal volume loss in adults with HIV.

Authors:  Margarita Bronshteyn; Fan Nils Yang; Kyle F Shattuck; Matthew Dawson; Princy Kumar; David J Moore; Ronald J Ellis; Xiong Jiang
Journal:  Hum Brain Mapp       Date:  2021-06-05       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.